Finance360

🔍 Backtest Before You Trade – Analyze Market Behavior First!
📊 See Market Trends Clearly – Visual Graphs, Smarter Insights!
📈 Data-Driven Insights, Not Predictions – Make Informed Decisions!
⚡ Take Your Analysis to the Next Level – Get Premium AFL Scripts!
You can also listen to this post
Premarket Report – April 27, 2026
For more daily updates join our WhatsApp channel Join Now

Premarket Report – April 27, 2026

Premarket Updates

  • GIFT Nifty : GIFT Nifty futures at 24,120 (+0.70%), indicating a mildly positive bias for the Indian market open amid Sun Pharma's major acquisition and India-New Zealand FTA signing.
  • Asia Markets: Asian indices trading mixed; energy stocks firm on elevated crude while select pharma and export plays gain on corporate deals and trade pacts.
  • Nifty Futures: Nifty 50 futures near 24,050 (+0.65%); pointing to a flat-to-positive opening with focus on Q4 earnings continuation and geopolitical developments.
  • Bank Nifty Futures: Bank Nifty futures near 56,400 (+0.55%); banking pack showing resilience amid steady bond yields and domestic flows.
  • Midcaps Under Watch: Nifty Midcap futures around 13,750 (-0.15%); broader mid and smallcap segments mixed with selective buying in defensives.
  • IT Futures: Nifty IT futures under mild pressure tracking global tech cues but supported by overall market sentiment ahead of remaining earnings.
  • Rupee Under Watch: USD/INR near 94.20, trading with a cautious bias on oil prices and institutional flows.
  • FII/DII Flows: FIIs were net sellers of Rs 8,827 cr in cash on Apr 24; DIIs countered strongly as net buyers of Rs 4,700 cr, providing domestic support.
  • Sector Focus: Pharma in focus on Sun Pharma-Organon deal; energy on crude movements; infrastructure and select exports may benefit from India-NZ FTA; defensives likely stable.

Global Market Insights

US Markets (Recent Close)

  • Dow Jones: 49,230 (-0.16%)
  • S&P 500: 7,165 (+0.80%)
  • Nasdaq: 24,836 (+1.63%)
  • VIX (CBOE): moderating but remains sensitive to oil and geopolitics

US indices ended mixed to higher with tech strength offsetting energy volatility; focus now on upcoming earnings and Middle East developments.

Asia & Europe (Apr 27 Premarket)

  • Shanghai Composite: mixed on policy and commodity cues
  • Nikkei 225: cautious amid yen moves and global risk sentiment
  • FTSE Futures: modest gains with attention on corporate earnings
  • DAX Futures: steady with selective strength in defensives

Asian and European futures reflect mixed sentiment with oil prices and trade developments in focus.

Commodities & Forex

  • Brent Crude: ~$106.50 (firm on ongoing Hormuz and geopolitical concerns)
  • Gold: holding steady on safe-haven demand
  • US Dollar Index: selective strength against EM currencies

Oil remains elevated due to persistent supply worries; gold sees support while the dollar trades with a mild bias amid macro data.

Indian Market Pulse

Key Indices (Premarket)

  • GIFT Nifty Futures: ~24,120 (+0.70%)
  • Nifty 50 (Apr 24 Close): 23,897.95 (-1.14%)
  • Sensex (Apr 24 Close): 76,664.21 (-1.29%)
  • India VIX: moderating slightly but sensitive to global cues

Markets likely to open on a mildly positive note tracking GIFT Nifty, with key focus on corporate deals, FTA signing, and crude oil trajectory.

Key Futures (Premarket)

  • Nifty 50 Futures: ~24,050 (+0.65%)
  • Nifty Bank Futures: ~56,400 (+0.55%)
  • Nifty IT Futures: mixed tracking global tech and earnings
  • Nifty Midcap Futures: ~13,750 (-0.15%)

Futures suggest a cautious positive bias with buying interest possible in pharma and select sectors amid domestic support.

Top Movers (Recent Close)

GainersLosers
Pharma & select defensives on deal flows IT names on earnings reaction
Energy stocks on crude firmness Select financials amid FII flows
Infrastructure on policy/FTA optimism Midcaps on selective profit booking

Pharma resilient on major acquisition news; IT and growth sectors under pressure while energy holds amid oil levels.

Latest Global & Indian Market News

Sun Pharma to Acquire Organon in $11.75 Bn Deal

India's Sun Pharmaceutical Industries announces all-cash acquisition of US-listed women's health focused firm Organon, one of the largest outbound pharma deals.

India & New Zealand Sign Landmark FTA Today

India and New Zealand to ink Free Trade Agreement providing 100% duty-free access for Indian exports and boosting bilateral trade and investments.

Brent Crude Holds Above $106 on Geopolitical Cues

Ongoing concerns around Strait of Hormuz and Middle East developments keep oil prices firm, impacting import costs and inflation outlook for India.

DIIs Continue Strong Buying Amid FII Selling

Domestic institutions remain net buyers providing crucial support even as foreign investors stayed cautious in recent sessions.

IT Sector Watches Remaining Q4 Earnings

After mixed results last week, focus shifts to upcoming commentary from key players amid global demand trends.

US Markets Close Mixed on Tech Strength

Wall Street ended with Nasdaq gains while Dow was steady; investors monitor oil volatility and upcoming corporate results.

Rupee Trades Cautiously Near 94.20

Indian rupee shows a softer bias against the dollar influenced by oil prices and institutional activity.

Select Sectors Eye Benefits from New Trade Pact

Exporters and certain industries expected to gain from India-New Zealand FTA signing today.

Options Analysis

Nifty 50 Options Open Interest (OI)

Put OI concentration at lower strikes offers support while Call OI buildup at higher levels indicates resistance; volatility expected around earnings and macro events.

StrikeCall OI (Lakhs)Put OI (Lakhs)
23,800ModerateHigh
24,000BuildingSignificant
24,100IncreasingModerate
24,200Peak Call OIBuilding

Chart: Nifty 50 OI distribution (indicative; levels adjusted to recent range).

Disclaimer: Market data is based on the latest available information. GIFT Nifty price and other futures data are indicative and must be verified in real-time before trading. Investments are subject to market risks.

What Our Customers Say

“Amazing AFL scripts! They’ve transformed my trading strategy.” - John D.
“The exploration tools are top-notch. Highly recommend!” - Sarah K.
“Backtesting has never been easier. Great work!” - Michael T.
“HTML outputs are clean and professional. Love it!” - Emily R.
“The calculators are a game-changer for my analysis.” - David L.
“Customer support is fantastic. Very responsive!” - Lisa M.
“I’ve seen a noticeable improvement in my trading results.” - Robert P.
“The AFLs are well-documented and easy to use.” - Anna S.
“Great value for the price. Worth every penny!” - James W.
“I love the variety of tools available. Something for everyone!” - Karen H.